Development and Validation of Staging Systems for AA Amyloidosis

What is it about?

AA amyloidosis is a rare disease characterized by the presence of renal involvement in almost all cases. Despite the typically good survival, progression to end-stage renal failure is frequent and affects quality of life. We identified and validated for the first time biomarker-based staging systems able to identify patients with more advanced disease at diagnosis.

Featured Image